SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bayer Wins China Approval for Asundexian, First FXIa Inhibitor

Bayer received marketing authorization from China's NMPA for Sunharbro (asundexian) 50 mg.

BAYRY

Related stories